Kathleen I. Pritchard
机构: Professor, Division of Medical Oncology, University of Toronto
每年引用次数
引用次数
引用: 97,394
H-指数: 121
I10-指数 : 386
出版物: 803
Update of the Oxford Overview: New Insight and Perspectives in the Era of Personalized Medicine
Kathleen I. Pritchard , Jonas Bergh , Harold J. Burstein
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting ( 32) 71 -79
2
2012
Commentary: Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era?
Kathleen I. Pritchard
Oncologist 14 ( 10) 959 -962
3
2009
Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer
Daphne T. Tsoi , Miho Inoue , Catherine M. Kelly , Sunil Verma
Oncologist 15 ( 5) 457 -465
124
2010
Review of the Clinical Studies Using the 21-Gene Assay
Catherine M. Kelly , Ellen Warner , Daphne T. Tsoi , Sunil Verma
Oncologist 15 ( 5) 447 -456
14
2010
A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium
Sara K. Taylor , Stephen Chia , Susan Dent , Mark Clemons
Oncologist 15 ( 8) 810 -818
48
2010
Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: The adjuvant lapatinib and/or trastuzumab treatment optimization experience
Otto Metzger‐Filho , Evandro Azambuja , Ian Bradbury , Kamal S. Saini
Oncologist 18 ( 2) 134 -140
19
2013
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
Maggie C.U. Cheang , Miguel Martin , Torsten O. Nielsen , Aleix Prat
Oncologist 20 ( 5) 474 -482
78
2015
Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer
Kathleen I. Pritchard , Stephen K. Chia , Christine Simmons , Deanna McLeod
Oncologist 22 ( 1) 12 -24
9
2017
Prospective Evaluation of the Impact of the 21‐Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node‐Positive Breast Cancer in Ontario, Canada
Sofia Torres , Maureen Trudeau , Sonal Gandhi , Ellen Warner
Oncologist 23 ( 7) 768 -775
8
2018
Attitudes of Canadian oncology practitioners toward psychosocial interventions in clinical and research settings in women with breast cancer.
M. Elizabeth Del Giudice , Molyn Leszcz , Kathleen I. Pritchard , Leslie Vincent
Psycho-oncology 6 ( 3) 178 -189
30
1997
The Fox guarding the clinical trial: internal vs. external validity in randomized studies.
Pamela J. Goodwin , Kathleen I. Pritchard , David Spiegel
Psycho-oncology 8 ( 3) 275 -275
9
1999
An update on adjuvant systemic therapy for elderly patients with early breast cancer
Katarzyna J. Jerzak , Danielle N. Desautels , Kathleen I. Pritchard
Expert Opinion on Pharmacotherapy 17 ( 14) 1881 -1888
1
2016
An update on treatment for post-menopausal metastatic breast cancer in elderly patients.
Ines B. Menjak , Katarzyna J. Jerzak , Danielle N. Desautels , Kathleen I. Pritchard
Expert Opinion on Pharmacotherapy 19 ( 6) 597 -609
2018
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study
Dennis C. Sgroi , Judy-Anne W. Chapman , T. Badovinac-Crnjevic , Elizabeth Zarella
Breast Cancer Research 18 ( 1) 1 -7
38
2016
Tamoxifen-associated hot flashes in women.
Domingo G. Pérez , Katherine M. Zahasky , Charles L. Loprinzi , Jeff Sloan
Supportive Cancer Therapy 4 ( 3) 152 -156
4
2007
The Combination of p53 Mutation and neu/erbB-2 Amplification Is Associated With Poor Survival in Node-Negative Breast Cancer
Shelley B. Bull , Hilmi Ozcelik , Dushanthi Pinnaduwage , Martin E. Blackstein
Journal of Clinical Oncology 22 ( 1) 86 -96
92
2004
Health-Related Quality of Life and Psychosocial Status in Breast Cancer Prognosis: Analysis of Multiple Variables
Pamela J. Goodwin , Marguerite Ennis , Louise J. Bordeleau , Kathleen I. Pritchard
Journal of Clinical Oncology 22 ( 20) 4184 -4192
84
2004
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Aron Goldhirsch , Eric P Winer , AS Coates , RD Gelber
Annals of Oncology 24 ( 9) 2206 -2223
3,775
2013
Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17
Edith A. Perez , Robert G. Josse , Kathleen I. Pritchard , James N. Ingle
Journal of Clinical Oncology 24 ( 22) 3629 -3635
255
2006
Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.
Wendy R. Parulekar , Andrew G. Day , Jon A. Ottaway , Lois E. Shepherd
Journal of Clinical Oncology 23 ( 25) 6002 -6008
110
2005